Fingerprint
Dive into the research topics of 'Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody® targeting the DR5 receptor'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody® targeting the DR5 receptor
Kyriakos P. Papadopoulos, Randi Isaacs, Sanela Bilic, Kerstin Kentsch, Heather A. Huet, Matthias Hofmann, Drew Rasco, Nicole Kundamal, Zhongwhen Tang, Jennifer Cooksey, Amit Mahipal
Research output: Contribution to journal › Article › peer-review
72
Scopus
citations